Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
6,465,692
-
Share change
-
-585,831
-
Total reported value
-
$177,790,378
-
Price per share
-
$27.50
-
Number of holders
-
43
-
Value change
-
-$18,348,502
-
Number of buys
-
16
-
Number of sells
-
25
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q1 2016
As of 31 Mar 2016,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,465,692 shares.
The largest 10 holders included
FMR LLC, Cormorant Asset Management, LLC, ORBIMED ADVISORS LLC, Tekla Capital Management LLC, LAZARD ASSET MANAGEMENT LLC, FRANKLIN RESOURCES INC, Artal Group S.A., TAUBE HODSON STONEX PARTNERS LLP, CLOUGH CAPITAL PARTNERS L P, and Abingworth LLP.
This page lists
43
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.